NasdaqGS - Delayed Quote USD

Zynex, Inc. (ZYXI)

11.21 +0.27 (+2.47%)
At close: April 26 at 4:00 PM EDT
10.94 -0.27 (-2.41%)
After hours: April 26 at 6:43 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Thomas Sandgaard Founder, President, CEO & Chairman 992.83k 1.66M 1959
Mr. Daniel J. Moorhead Chief Financial Officer 472.61k -- 1972
Ms. Anna Lucsok Chief Operating Officer 400.84k -- 1987
Mr. Steve Fox Vice President Of Sales -- -- --
Mr. Donald Gregg President of Zynex Monitoring Solutions -- -- --
Mr. Neil Friery President & COO of Zynex Monitoring Solutions, Inc. -- -- --

Zynex, Inc.

9655 Maroon Circle
Englewood, CO 80112
United States
303 703 4906 https://www.zynex.com
Sector: 
Healthcare
Full Time Employees: 
1,100

Description

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Corporate Governance

Zynex, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 7. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 3; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Apr 30, 2024
Zynex, Inc. Earnings Call

Related Tickers

HSIC Henry Schein, Inc.
73.13
+0.43%
 
PDCO Patterson Companies, Inc.
25.77
-0.12%
 
OMI Owens & Minor, Inc.
25.09
+4.02%
 
CAH Cardinal Health, Inc.
103.21
-0.58%
 
YI 111, Inc.
1.0300
+1.98%
 
COR Cencora, Inc.
240.88
+0.47%
 
MCK McKesson Corporation
543.30
+0.62%